Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -31,335 | -25,296 | -22,145 | -1,913 | 0 |
| Depreciation Amortization | 107 | 71 | 41 | 1 | 0 |
| Accounts payable and accrued liabilities | 1,240 | 443 | 300 | 29 | N/A |
| Other Working Capital | 1,832 | 53 | 466 | -94 | 0 |
| Other Operating Activity | 16,828 | 17,339 | 17,300 | -347 | 0 |
| Operating Cash Flow | $-11,328 | $-7,390 | $-4,038 | $-2,324 | $0 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -90,285 | -20,322 | -25,722 | N/A | N/A |
| PPE Investments | -1,747 | -883 | -877 | -324 | 0 |
| Investing Cash Flow | $-92,032 | $-21,205 | $-26,599 | $-324 | $0 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 108 | 108 | 42 | 42 | N/A |
| Dividend Paid | 95,569 | 95,569 | 20,730 | 3,995 | 0 |
| Other Financing Activity | -729 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $94,948 | $95,677 | $20,772 | $4,037 | $0 |
| Beginning Cash Position | 12,517 | 12,517 | 12,517 | 12,517 | 0 |
| End Cash Position | 4,105 | 79,599 | 2,652 | 13,906 | 0 |
| Net Cash Flow | $-8,412 | $67,082 | $-9,865 | $1,389 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | -11,328 | -7,390 | -4,038 | -2,324 | 0 |
| Capital Expenditure | -1,747 | -883 | -877 | -324 | N/A |
| Free Cash Flow | -13,075 | -8,273 | -4,915 | -2,648 | 0 |